Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
1231.HK Stock Summary
In the News
1231.HK Financial details
Company Rating
Neutral
Market Cap
2.72B
Income
-43.07M
Revenue
1.52B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
23
Optionable
No
Shortable
Yes
Earnings
24 Mar 2023
P/E
0
Forward P/E
-
PEG
-
P/S
1.72
P/B
-
P/C
-
P/FCF
-257.03
Quick Ratio
0.35
Current Ratio
1.43
Debt / Equity
0.17
LT Debt / Equity
0.01
-
-
EPS (TTM)
-0.01
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
34.22%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-2.94%
SMA50
-1.49%
SMA100
1.54%
Inst Own
-
Inst Trans
-
ROA
-4%
ROE
-8%
ROC
-0.05%
Gross Margin
1%
Oper. Margin
-1%
Profit Margin
-1%
Payout
-
Shs Outstand
4B
Shs Float
1.13B
-
-
-
-
Target Price
-
52W Range
0.59-1.0
52W High
-
52W Low
-
RSI
32.07
Rel Volume
-
Avg Volume
7.66K
Volume
Perf Week
-4.41%
Perf Month
-4.41%
Perf Quarter
-
Perf Half Y
0%
-
-
-
-
Beta
0.624371
-
-
Volatility
0.02%, 0.01%
Prev Close
0%
Price
0.65
Change
0%
1231.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 0.01 | 0.07 | 0.12 | 0.07 | 0 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | -0.01 | 0 | 0 | 0 | |
Free cash flow per share | 0 | -0.01 | 0 | 0 | 0 | |
Cash per share | 0.01 | 0.01 | 0 | 0.01 | 0 | |
Book value per share | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
Tangible book value per share | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
Share holders equity per share | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
Interest debt per share | 0.01 | 0.02 | 0.01 | 0 | 0 | |
Market cap | 3.27B | 3.43B | 2.32B | 2.61B | 0 | |
Enterprise value | 3.29B | 3.49B | 2.32B | 2.6B | -6.91M | |
P/E ratio | -211.91 | -1.09K | 2.75K | -1.47K | 0 | |
Price to sales ratio | 70.8 | 12.48 | 4.96 | 8.92 | 0 | |
POCF ratio | -400.57 | -163.03 | 185.71 | 164.75 | 0 | |
PFCF ratio | -395.01 | -161.98 | 186.62 | 166.64 | 0 | |
P/B Ratio | 79.21 | 111.35 | 74.66 | 89.33 | 0 | |
PTB ratio | 79.21 | 111.35 | 74.66 | 89.33 | 0 | |
EV to sales | 71.18 | 12.7 | 4.97 | 8.89 | -0.03 | |
Enterprise value over EBITDA | -631.54 | 1.81K | 841.71 | 3.23K | 5.78 | |
EV to operating cash flow | -402.72 | -165.97 | 186.13 | 164.18 | 5.14 | |
EV to free cash flow | -397.13 | -164.9 | 187.05 | 166.06 | 5.12 | |
Earnings yield | 0 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0 | -0.01 | 0.01 | 0.01 | 0 | |
Debt to equity | 0.77 | 2.42 | 0.66 | 0.19 | 0.17 | |
Debt to assets | 0.36 | 0.47 | 0.15 | 0.14 | 0.08 | |
Net debt to EBITDA | -3.38 | 31.98 | 1.93 | -11.24 | 5.78 | |
Current ratio | 1.22 | 1.18 | 1.15 | 2.95 | 1.43 | |
Interest coverage | -7.77 | 0.46 | 1.67 | 0.58 | -2 | |
Income quality | 0.52 | 2.1 | 11.82 | -9.13 | 0.6 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.1 | 0.01 | 0 | 0.01 | 0.01 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0.01 | 0.01 | 0 | -0.01 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | -0.18 | -0.23 | -0.45 | -0.82 | -0.02 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.03 | 0.01 | 0.01 | 0.01 | 0 | |
ROIC | -0.1 | 0.01 | 0.09 | 0.08 | -0.12 | |
Return on tangible assets | -0.17 | -0.02 | 0.01 | -0.05 | -0.04 | |
Graham Net | -0.01 | -0.03 | -0.02 | 0 | 0 | |
Working capital | 10.73M | 21.71M | 15.34M | 14.39M | 14.01M | |
Tangible asset value | 40.56M | 30.06M | 32.05M | 30.23M | 27.98M | |
Net current asset value | 10.66M | 11.47M | 15.24M | 14.23M | 13.83M | |
Invested capital | 0.77 | 2.42 | 0.66 | 0.19 | 0.17 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 6.14M | 18.36M | 59.17M | 41.63M | 13.35M | |
Average inventory | 624.26K | 206.72K | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 1.31 | 49.38 | 64.78 | 1.87 | 46.36 | |
Days of inventory on hand | 3.31 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 278.57 | 7.39 | 5.63 | 195.03 | 7.87 | |
Inventory turnover | 110.19 | 0 | 0 | 0 | 0 | |
ROE | -0.37 | -0.1 | 0.03 | -0.06 | -0.08 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2022-12-31 for Q4
Metric | History | 2020-12-31 | 2021-06-30 | 2021-12-31 | 2022-06-30 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 0 | 0 | |
Book value per share | 0 | 0 | 0 | 0 | 0 | |
Tangible book value per share | 0 | 0 | 0 | 0 | 0 | |
Share holders equity per share | 0 | 0 | 0 | 0 | 0 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 0 | 0 | 0 | 0 | 0 | |
Enterprise value | 5.32M | -6.71M | -9.05M | -7.94M | -6.91M | |
P/E ratio | 0 | 0 | 0 | 0 | 0 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0 | 0 | 0 | 0 | 0 | |
PTB ratio | 0 | 0 | 0 | 0 | 0 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | 0 | 0 | 0 | 0 | 0 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0.66 | 0.18 | 0.19 | 0.16 | 0.17 | |
Debt to assets | 0.15 | 0.04 | 0.14 | 0.07 | 0.08 | |
Net debt to EBITDA | 0 | 0 | 0 | 0 | 0 | |
Current ratio | 1.15 | 1.15 | 2.95 | 1.43 | 1.43 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 0 | 0 | 0 | 0 | |
ROIC | 0 | 0 | 0 | 0 | 0 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | 0 | 0 | 0 | 0 | 0 | |
Working capital | 15.34M | 16.93M | 14.39M | 15.44M | 14.01M | |
Tangible asset value | 32.05M | 33.18M | 30.23M | 30.43M | 27.98M | |
Net current asset value | 15.24M | 16.89M | 14.23M | 15.32M | 13.83M | |
Invested capital | 0.66 | 0.18 | 0.19 | 0.16 | 0.17 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | 0 | 0 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
1231.HK Frequently Asked Questions
What is Newton Resources Ltd stock symbol ?
Newton Resources Ltd is a HK stock and trading under the symbol 1231.HK
What is Newton Resources Ltd stock quote today ?
Newton Resources Ltd stock price is $0.65 today.
Is Newton Resources Ltd stock public?
Yes, Newton Resources Ltd is a publicly traded company.